BIOMAT Database Logo BIOMAT Database Logo

Histocompatibility-linked immune-response determinants in multiple sclerosis. 1973

C Jersild, and B Dupont, and T Fog, and G S Hansen, and L S Nielsen, and M Thomsen, and A Svejgaard

UI MeSH Term Description Entries
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006649 Histocompatibility Antigens A group of antigens that includes both the major and minor histocompatibility antigens. The former are genetically determined by the major histocompatibility complex. They determine tissue type for transplantation and cause allograft rejections. The latter are systems of allelic alloantigens that can cause weak transplant rejection. Transplantation Antigens,Antigens, Transplantation,Histocompatibility Antigen,LD Antigens,SD Antigens,Antigen, Histocompatibility,Antigens, Histocompatibility,Antigens, LD,Antigens, SD
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

C Jersild, and B Dupont, and T Fog, and G S Hansen, and L S Nielsen, and M Thomsen, and A Svejgaard
Letter: Histocompatibility determinants in multiple sclerosis.
February 1974, Lancet (London, England),
C Jersild, and B Dupont, and T Fog, and G S Hansen, and L S Nielsen, and M Thomsen, and A Svejgaard
Histocompatibility-linked immune response genes.
January 1972, Science (New York, N.Y.),
C Jersild, and B Dupont, and T Fog, and G S Hansen, and L S Nielsen, and M Thomsen, and A Svejgaard
Proceedings: Multiple sclerosis susceptibility and histocompatibility determinants.
May 1975, Neurology,
C Jersild, and B Dupont, and T Fog, and G S Hansen, and L S Nielsen, and M Thomsen, and A Svejgaard
The histocompatibility-linked immune response genes.
January 1975, Advances in cancer research,
C Jersild, and B Dupont, and T Fog, and G S Hansen, and L S Nielsen, and M Thomsen, and A Svejgaard
Histocompatibility determinants in Israeli Jewish patients with multiple sclerosis.
October 1977, Tissue antigens,
C Jersild, and B Dupont, and T Fog, and G S Hansen, and L S Nielsen, and M Thomsen, and A Svejgaard
Histocompatibility-linked immune-response genes in the rhesus monkey.
June 1974, Transplantation proceedings,
C Jersild, and B Dupont, and T Fog, and G S Hansen, and L S Nielsen, and M Thomsen, and A Svejgaard
HLA-linked and unlinked determinants of multiple sclerosis.
January 1982, Immunogenetics,
C Jersild, and B Dupont, and T Fog, and G S Hansen, and L S Nielsen, and M Thomsen, and A Svejgaard
Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.
December 1980, Journal of epidemiology and community health,
C Jersild, and B Dupont, and T Fog, and G S Hansen, and L S Nielsen, and M Thomsen, and A Svejgaard
Histocompatibility-linked immune-response genes. What do they do?
December 1973, Transplantation proceedings,
C Jersild, and B Dupont, and T Fog, and G S Hansen, and L S Nielsen, and M Thomsen, and A Svejgaard
The Immune Response in Multiple Sclerosis.
January 2022, Annual review of pathology,
Copied contents to your clipboard!